CSPR · Casper Sleep Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q4 '18 | Q4 '17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $156.53M | $151.76M | $127.68M | - | $123.46M | $110.20M | $113.04M | - | - | - |
| Cost of Revenue | $92.63M | $79.22M | $60.99M | - | $54.94M | $53.13M | $60.08M | - | - | - |
| Gross Profit | $63.90M | $72.53M | $66.68M | - | $64.71M | $46.69M | $52.96M | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $46.14M | $48.16M | $44.50M | - | $39.52M | $42.02M | $48.30M | - | - | - |
| Total Operating Expenses | $86.97M | $105.64M | $85.44M | - | $86.54M | $79.33M | $85.77M | - | - | - |
| D&A | - | - | $3.82M | - | $2.08M | $1.41M | $4.13M | - | - | - |
| Operating Income | ($23.06M) | ($33.11M) | ($18.75M) | - | ($21.83M) | ($26.40M) | ($32.81M) | - | - | - |
| Interest Expense | $2.08M | - | - | - | - | - | - | - | - | - |
| Income Tax | $16.0K | $17.0K | $19.0K | - | $20.0K | $10.0K | $16.0K | - | - | - |
| Net Income | ($25.27M) | ($33.75M) | ($21.18M) | - | ($23.02M) | ($26.93M) | ($34.47M) | - | - | - |
| EPS - Basic | ($0.40) | ($0.61) | ($1.23) | - | - | - | - | - | - | - |
| EPS - Diluted | ($0.40) | ($0.61) | ($1.23) | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q4 '18 | Q4 '17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43.10M | $49.66M | $61.63M | $88.92M | $96.13M | $98.22M | $67.58M | - | $26.88M | $98.88M |
| Accounts Receivable | $31.18M | $33.05M | $24.54M | $27.66M | $17.57M | $23.38M | $31.06M | - | - | - |
| Inventory | $76.33M | $58.05M | $46.84M | $35.53M | $34.27M | $37.22M | $38.87M | - | - | - |
| Accounts Payable | $69.97M | $54.71M | $48.13M | $47.61M | $26.78M | $27.26M | $38.31M | - | - | - |
| Current Assets | $163.09M | $153.85M | $145.84M | $166.30M | $162.50M | $172.95M | $199.23M | - | - | - |
| Total Assets | $220.00M | $211.13M | $213.40M | $234.20M | $232.85M | $243.16M | $230.32M | - | - | - |
| Current Liabilities | $187.01M | $157.34M | $118.48M | $119.28M | $122.35M | $121.18M | $147.96M | - | - | - |
| Long-term Debt | $50.80M | $50.38M | $62.97M | $65.55M | - | - | - | $49.17M | - | - |
| Total Liabilities | $263.04M | $233.21M | $205.28M | $208.73M | $196.72M | $195.17M | $217.45M | - | - | - |
| Stockholders' Equity | ($43.04M) | ($22.08M) | $8.12M | $25.47M | ($284.25M) | ($263.62M) | $69.77M | - | - | ($136.71M) |
| Retained Earnings | ($495.01M) | ($469.74M) | ($436.00M) | ($414.81M) | ($399.79M) | ($383.93M) | ($325.26M) | - | - | - |
Cash Flow
| Line item | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q4 '18 | Q4 '17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($23.63M) | - | - | - | ($33.07M) | - | - | - |
| Investing Cash Flow | - | - | ($3.88M) | - | - | - | ($7.09M) | - | - | - |
| Financing Cash Flow | - | - | ($2.97M) | - | - | - | $88.26M | - | - | - |
| CapEx | - | - | $3.88M | - | - | - | $7.09M | - | - | - |
| Free Cash Flow | - | - | ($27.51M) | - | - | - | ($40.16M) | - | - | - |
Ratios
| Metric | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q4 '18 | Q4 '17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 40.8% | 47.8% | 52.2% | - | 52.4% | 42.4% | 46.9% | - | - | - |
| Operating margin | -14.7% | -21.8% | -14.7% | - | -17.7% | -24.0% | -29.0% | - | - | - |
| EBITDA margin | - | - | -11.7% | - | -16.0% | -22.7% | -25.4% | - | - | - |
| Net margin | -16.1% | -22.2% | -16.6% | - | -18.6% | -24.4% | -30.5% | - | - | - |
| Free cash flow margin | - | - | -21.5% | - | - | - | -35.5% | - | - | - |
| FCF / Net income | - | - | 1.30 | - | - | - | 1.17 | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 29.5% | 31.7% | 34.9% | - | 32.0% | 38.1% | 42.7% | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -11.5% | -16.0% | -9.9% | - | -9.9% | -11.1% | -15.0% | - | - | - |
| Return on equity | 58.7% | 152.8% | -260.8% | - | 8.1% | 10.2% | -49.4% | - | - | - |
| Return on invested capital | -235.0% | -92.4% | -20.8% | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.87 | 0.98 | 1.23 | 1.39 | 1.33 | 1.43 | 1.35 | - | - | - |
| Quick ratio | 0.46 | 0.61 | 0.84 | 1.10 | 1.05 | 1.12 | 1.08 | - | - | - |
| Cash ratio | 0.23 | 0.32 | 0.52 | 0.75 | 0.79 | 0.81 | 0.46 | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | -1.18 | -2.28 | 7.75 | 2.57 | - | - | - | - | - | - |
| Debt / Assets | 0.23 | 0.24 | 0.30 | 0.28 | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -11.1x | - | - | - | - | - | - | - | - | - |
| Equity multiplier | -5.11 | -9.56 | 26.28 | 9.20 | -0.82 | -0.92 | 3.30 | - | - | - |
| Liabilities / Assets | 1.20 | 1.10 | 0.96 | 0.89 | 0.84 | 0.80 | 0.94 | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.71 | 0.72 | 0.60 | - | 0.53 | 0.45 | 0.49 | - | - | - |
| Inventory turnover | 1.21 | 1.36 | 1.30 | - | 1.60 | 1.43 | 1.55 | - | - | - |
| Days sales outstanding | 73d | 79d | 70d | - | 52d | 77d | 100d | - | - | - |
| Days inventory outstanding | 301d | 267d | 280d | - | 228d | 256d | 236d | - | - | - |
| Days payable outstanding | 276d | 252d | 288d | - | 178d | 187d | 233d | - | - | - |
| Cash conversion cycle | 98d | 95d | 62d | - | 102d | 146d | 104d | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 26.8% | 37.7% | 12.9% | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | -1.3% | 55.3% | 25.9% | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -5.6% | -25.4% | 42.8% | - | - | - | - | - | - | - |
| Net income growth (YoY) | -9.8% | -25.3% | 38.5% | - | - | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | 31.5% | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 84.9% | 91.6% | -88.4% | - | - | - | - | - | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2020-12-31.
Geographic
$497.00M totalNorth America$485.03M · 97.6%
European Union$11.97M · 2.4%
Peer comparison
Same SIC group: Household Furniture
Comparing Casper Sleep Inc. against the 5 most active filers in the same SIC group.